Joaquin Mira, MD
Radiation Oncology · San Antonio, TXNPI 1831126127
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 20 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 12 manufacturers, the largest accounting for just 17.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $186 and has fallen 89.6% since, to $19 in 2023. That places this record below the midpoint for radiation oncology clinicians in TX, where the typical reported total is $554.
Across 20 payments — averaging $20.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pharmacosmos Therapeutics Inc.$70
- Amgen$69
- Novartis$63
- Puma Biotechnology, Inc.$42
- Eisai Inc.$33
- Karyopharm Therapeutics Inc.$21
- plus $112 from 6 others
Across 10 payments — averaging $538.68 each. An ownership or investment interest held by the physician or an immediate family member.
- Reflexion Medical, Inc.$5K
What the payments were for
- Food & beverage$411100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pharmacosmos Therapeutics Inc. | 3 | $70 |
| Amgen | 3 | $69 |
| Novartis | 3 | $63 |
| Puma Biotechnology, Inc. | 2 | $42 |
| Eisai Inc. | 2 | $33 |
| Karyopharm Therapeutics Inc. | 1 | $21 |
| Daiichi Sankyo Inc. | 1 | $21 |
| AbbVie | 1 | $19 |
| Boston Scientific | 1 | $19 |
| Pfizer | 1 | $18 |
| Sanofi | 1 | $17 |
| Astellas Pharma US Inc | 1 | $17 |
How this compares
$411 in reported general payments places this provider in the 40th percentile of 418 radiation oncology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other radiation oncology in San Antonio
- Richard TuliSan Antonio$11K
- William JonesSan Antonio$8K
- Bryan LinSan Antonio$5K
- James WelshHouston$421K
- Stephen ChunHouston$344K
- Jim HsiangCorpus Christi$258K
- Chad TangHouston$183K
- Phuoc TranHouston$177K
- Hak ChoyDallas$119K
- Steven LinHouston$105K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.